Asia Pacific PEGylated Proteins Market By Protein Type (Interferons, Erythropoietin, MAbs), Services, Application (Chronic Kidney Diseases, Cancer Treatment), By Consumables (Reagents, PEGylation Kits), End-User (Pharmaceutical & Biotechnology Companies, CROs, Academic Research Institutes) And By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2016–2021)
Asia Pacific PEGylated Proteins Market By Protein Type (Interferons, Erythropoietin, MAbs), Services, Application (Chronic Kidney Diseases, Cancer Treatment), By Consumables (Reagents, PEGylation Kits), End-User (Pharmaceutical & Biotechnology Companies, CROs, Academic Research Institutes) And By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2016–2021)
ID: 3358 | Pages: 139 | September 2017 | Region: Asia Pacific
The Asia Pacific PEGylated Proteins Market was worth USD 124.31 million in 2016 and estimated to be growing at a CAGR of 12.50%, to reach USD 224.01 million by 2021. The market is showing great potential in the forecast period, i.e. till 2021. PEGylation is a process of attachment of covalent or non-covalent bond of PolyEthylene Glucol (PEG) polymer chains to molecules and macrostructures, like protein in case of PEGylation of proteins. PEGylated Proteins have become very important because PEGylation of proteins help to protect protein against enzymatic dehydration and it also increases the half-life of drugs.
Increasing R and D investments on pharmaceuticals and healthcare sector in this region because of increasing awareness of people regarding health related issues due to government campaigns, higher population in this region, high risk of diseases, increase in adoption of protein based drugs over non-protein based drugs and increased half-life of drugs due to PEGylation are the major driving factors of this market. On the other hand, the unpredictable accumulation of high molecular weight compounds in liver might lead to inclusion bodies with no known consequences. Furthermore, chain length of these compounds can change which might lead to unexpected clearance times in vivo. These concerning matters are challenging this market.
The Asia Pacific market for PEGylated Proteins is broadly categorized into Protein Type, Services, Applications, consumable and by end-users. On the basis of Protein types, it is further sub-categorized into Interferons, erythropoietin and mAbs. On the basis of Applications, It is sub-categorized into Chronic Kidney Disease and Cancer treatment applications. On the basis of consumables, it is segmented into Reagents and PEGylation kits. On the basis of End-Users, it is analysed under Pharmaceutical & Biotechnology Companies, CROs and academic research institutes. On the basis of End-Users, Pharmaceutical & Biotechnology Companies are the biggest sector for this market.
Geographically, this market has been sub-categorized into India, China, Japan, South Korea and Australia. Asia-Pacific is the fastest growing region among all the segments mentioned in the global report for this market. India and China are leading the way in this market in terms of market share whereas in terms of technological advances, Japan is ahead of other countries in this region.
Some of the major companies dominating the market, by their products and services include Laysan Bio, Ltd., Iris Biotech GmbH, Biomatrik Inc., Quanta BioDesign Ltd., Cealares GmbH, Creative PEGworks, Jenkem Technology USA Inc., NOF Corporation, Thermo Fisher Scientific Inc., and Merck Millipore.
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Protein Type
5.1.1 Introduction
5.1.2 Interferons
5.1.3 Erythropoietin
5.1.4 mAbs
5.1.5 Y-o-Y Growth Analysis, By Protein Type
5.1.6 Market Attractiveness Analysis, By Protein Type
5.1.7 Market Share Analysis, By Protein Type
5.2 Consumables
5.2.1 Introduction
5.2.2 Reagents
5.2.3 PEGylation Kits
5.2.4 Y-o-Y Growth Analysis, By Consumables
5.2.5 Market Attractiveness Analysis, By Consumables
5.2.6 Market Share Analysis, By Consumables
5.3 Application
5.3.1 Introduction
5.3.2 Chronic Kidney Diseases
5.3.3 Cancer Treatment
5.3.4 Y-o-Y Growth Analysis, By Application
5.3.5 Market Attractiveness Analysis, By Application
5.3.6 Market Share Analysis, By Application
5.4 End-Users
5.4.1 Introduction
5.4.2 Pharmaceuticals & Biotechnology Companies
5.4.3 CROs
5.4.4 Academic Research Institutes
5.4.5 Y-o-Y Growth Analysis, By End-Users
5.4.6 Market Attractiveness Analysis, By End-Users
5.4.7 Market Share Analysis, By End-Users
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Protein Type
6.1.3.3 By Consumables
6.1.3.4 By Application
6.1.3.5 By End-Users
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Protein Type
6.1.4.3 By Consumables
6.1.4.4 By Application
6.1.4.5 By End-Users
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Protein Type
6.1.5.3 By Consumables
6.1.5.4 By Application
6.1.5.5 By End-Users
6.2 China
6.3 India
6.4 Japan
6.5 South Korea
6.6 Australia
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 Laysan Bio Ltd.
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Iris Biotech GmbH
8.3 Biomatrik Inc.
8.4 Quanta BioDesign Ltd.
8.5 Cealares GmbH
8.6 Creative PEGworks
8.7 Jenkem Technology USA Inc.
8.8 NOF Corporation
8.9 Thermo Fisher Scientific Inc.
8.10 Merck Millipore
9.Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
- Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
- Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
- Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
- Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
- Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
- A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
- Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
- An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
- Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
| Title | Price | Add To Cart |
- Asia-Pacific PEGylated Proteins Market By Protein Type, From 2016-2021 ( USD Billion )
- Asia-Pacific Interferons Market By Region, From 2016-2021 ( USD Billion )
- Asia-Pacific Erythropoietin Market By Region, From 2016-2021 ( USD Billion )
- Asia-Pacific mAbs Market By Region, From 2016-2021 ( USD Billion )
- Asia-Pacific PEGylated Proteins Market By End-User, From 2016-2021 ( USD Billion )
- Asia-Pacific Pharmaceuticals & Biotechnology Companies Market By Region, From 2016-2021 ( USD Billion )
- Asia-Pacific CROs Market By Region, From 2016-2021 ( USD Billion )
- Asia-Pacific Academic Research Institutes Market By Region, From 2016-2021 ( USD Billion )
- Asia-Pacific PEGylated Proteins Market By Application, From 2016-2021 ( USD Billion )
- Asia-Pacific Chronic Kidney Disease Market By Region, From 2016-2021 ( USD Billion )
- Asia-Pacific Cancer Treatment Market By Region, From 2016-2021 ( USD Billion )
- Asia-Pacific PEGylated Proteins Market By Consumables, From 2016-2021 ( USD Billion )
- Asia-Pacific Reagents Market By Region, From 2016-2021 ( USD Billion )
- Asia-Pacific PEGylation Kits Market By Region, From 2016-2021 ( USD Billion )
- Japan PEGylated Proteins Market By Protein Type, From 2016-2021 ( USD Billion )
- Japan PEGylated Proteins Market By End-User, From 2016-2021 ( USD Billion )
- Japan PEGylated Proteins Market By Application, From 2016-2021 ( USD Billion )
- Japan PEGylated Proteins Market By Consumables, From 2016-2021 ( USD Billion )
- China PEGylated Proteins Market By Protein Type, From 2016-2021 ( USD Billion )
- China PEGylated Proteins Market By End-User, From 2016-2021 ( USD Billion )
- China PEGylated Proteins Market By Application, From 2016-2021 ( USD Billion )
- China PEGylated Proteins Market By Consumables, From 2016-2021 ( USD Billion )
- India PEGylated Proteins Market By Protein Type, From 2016-2021 ( USD Billion )
- India PEGylated Proteins Market By End-User, From 2016-2021 ( USD Billion )
- India PEGylated Proteins Market By Application, From 2016-2021 ( USD Billion )
- India PEGylated Proteins Market By Consumables, From 2016-2021 ( USD Billion )
- Australia PEGylated Proteins Market By Protein Type, From 2016-2021 ( USD Billion )
- Australia PEGylated Proteins Market By End-User, From 2016-2021 ( USD Billion )
- Australia PEGylated Proteins Market By Application, From 2016-2021 ( USD Billion )
- Australia PEGylated Proteins Market By Consumables, From 2016-2021 ( USD Billion )
- South Korea PEGylated Proteins Market By Protein Type, From 2016-2021 ( USD Billion )
- South Korea PEGylated Proteins Market By End-User, From 2016-2021 ( USD Billion )
- South Korea PEGylated Proteins Market By Application, From 2016-2021 ( USD Billion )
- South Korea PEGylated Proteins Market By Consumables, From 2016-2021 ( USD Billion )
Licence Type 
Clients
Why buy reports from Market Data Forecast
Free Customization
Free report customization that helps you gain required information for always being one step ahead of the competition
Post Purchase Support
6 months of post purchase support via email and phone; serving your needs 24x7 and helping you troubleshoot any technical issues
Best Price guaranteed
Customer focused research services and expertly devised strategic analyses made into premium quality reports at lowest prices
Insightful Snapshots
Summarized overviews of entire reports into customized presentations to ascertain market estimations and driving forces at a quick glance